Fig. 2From: Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer’s diseaseExpression of inflammasome-related genes in PBMCs isolated from patients with AD and controls. a–h Expression levels of the indicated genes relative to GAPDH as determined by RT-qPCR analysis. *P < 0.05, ***P < 0.001, ****P < 0.001 versus control group, #P < 0.05, ##P < 0.01 versus aMCI group. n = 20 for control, n = 33 for aMCI, n = 33 for AD. Data are expressed as means ± SEM. One-way ANOVABack to article page